AEterna Zentaris, Inc.
(NASDAQ:AEZS)|
0.40 -0.07 (-14.89%) Dec 04 - Close |
|
|
|
After-Hours 0.42 +0.02 (5.00%) Thu, 4 Dec 2008 7:40 PM
- Compare AEZS with:
- View: Line | Candlestick
Company Profile
AEterna Zentaris, Inc.
1405,du Parc-
Quebec, Quebec, G1P 4P5
Canada - Map
Phone: (418) 652-8525
Fax: (418) 652-0881
Website: www.aezsinc.com
CEO: Dr. David J Mazzo, Ph.D.
Employees: 181
Sector: Healthcare
Industry Group: Drugs
Industry: Biotechnology
Medical biopharmaceutical company
A global biopharmaceutical company which is focused on endocrine therapy and oncology with expertise in drug discovery, development and commercialization, targeting the North American and European markets.
Recent news for AEZS
-
AEterna Zentaris to Present at Upcoming RBC Capital Markets Healthcare Conference
PR Newswire - 12 hours ago
-
PR Newswire - Yesterday at 7:30 ET
-
Outlook for Small Cap Biotechnology Companies Discussed in Wall Street Transcript Report
Wall Street Transcript - Nov 19 at 9:20 ET
-
New Star Analyst Rankings for AEterna Zentaris, Inc.
StarMine - Nov 16 at 9:33 ET
-
New Star Analyst Rankings for AEterna Zentaris, Inc.
StarMine - Nov 14 at 9:23 ET
-
AEterna Zentaris Reports Third Quarter 2008 Financial and Operating Results
PR Newswire - Nov 13 at 7:30 ET
-
Q3 2008 Aeterna Zentaris Inc. Earnings Release - Before Market Open
CCBN - Nov 13 at 7:07 ET
-
AEterna Zentaris to Announce Third Quarter 2008 Financial and Operating Results on November 13, 2008
PR Newswire - Nov 12 at 8:00 ET
-
Briefing.com - Nov 12 at 7:16 ET
-
PR Newswire - Nov 12 at 7:15 ET